CELERISTX

We are an international team of highly skilled experts from disciplines as computational chemistry, medicinal chemistry, biology and machine learning... We design and discover medicines for these incurable diseases through event-driven pharmacology by leveraging AI to design much-needed medicines... We design novel protein degraders to tackle challenging targets in oncology with our proprietary platform joining ML-enabled models and a high throughput experimentation process (Direct-to-Biology) for scalable and fast development of protein degraders.

Also known as: Celeris Therapeutics, Celeris Therapeutics GmbH, Celeris Therapeutics, Inc.

Registration numbers: FN 550442z (W)

VAT numbers: ATU76712158

Primary location: Menlo Park United States